Microembolism and Other Links Between Migraine and Stroke
Clinical and Pathophysiologic Update
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received June 13, 2022
- Accepted in final form November 1, 2022
- First Published December 15, 2022.
Article Versions
- Previous version (December 15, 2022 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Simona Sacco, MD,
- Andrea M. Harriott, MD, PhD,
- Cenk Ayata, MD, PhD,
- Raffaele Ornello, MD, PhD,
- Rodrigo Bagur, MD,
- Amado Jimenez-Ruiz, MD and
- Luciano A. Sposato, MD, MBA, FRCPC
- Simona Sacco, MD,
Simona Sacco reports personal fees as speaker or advisor from Abbott, Allergan-Abbvie, AstraZeneca, Eli Lilly, Lundbeck, Novartis, NovoNordisk, Pfizer, Teva; research grants from Allergan, Novartis, Uriach; fees for CME/education from Medscape, Neurodiem Ology Medical Education; compensation as chief section editor for the section Headache and Neurogenic Pain in Frontiers of Neurology.
NONE
non-financial support from Abbott, Allergan, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, Eli Lilly, Lundbeck, Medtronic, Novartis, Pfizer, Starmed, Teva.
2011-2015 Editorial Advisory Panel, Clinical Science2012-2016 Visiting Editor, The Journal of Headache and Pain2012-2020 Editorial Board, European Neurology2015-2020 Editorial Board, StrokeFrom 2016, Editorial Board, European Stroke JournalFrom 2017 Associate Editor, The Journal of Headache and Pain2018-2020 Review Editor in Stroke, Frontiers in NeurologyFrom 2018 Advisory Board, Neurological SciencesFrom 2018 Editorial Board, International Journal of Stroke2018-2020 Academic Editor, PLOS ONEFrom 2020 Assistant Editor, Stroke2020 Co-editor, The Journal of Headache and PainFrom 2020 Associate Editor in Stroke, Frontiers in NeurologyFrom 2021 Specialty Chief Editor in Headache and Pain Medicine, Frontiers in From 2022 member of the Editorial Board of Neurology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Novartis, Allergan, Uriach
Italian Ministry of Health Multi-center Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS). A collaborative study from the Italian Stroke Organization (ISO) Basic Science network (Prot. 2017CY3J3W)
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Andrea M. Harriott, MD, PhD,
None
NONE
Honoraria from Headache Cooperative of New England for lecture.
(1) Cephalalgia, Associate Editor, 2017 - 2022(2) Cephalalgia Reports, Associate Editor, 2017 - 2022(3) eNeurologicalSci, Associate Editor, 2018 - 2022
NONE
NONE
NONE
NONE
NONE
Unpaid authorship agreement - Abbvie
NONE
NONE
(1) NIH-NINDS, K08NS124991
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Cenk Ayata, MD, PhD,
(1) Omniox, Inc(2) Neurelis, Inc
NONE
None
(1) The Journal of Headache and Pain, Associate Editor, 2019-
NONE
NONE
NONE
(1) Bioaxone, Inc
NONE
NONE
NONE
(1) Electrocore, Inc.(2) Hovid Berhad, research grant
(1) NIH
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Raffaele Ornello, MD, PhD,
Eli Lilly
NONE
(1) Eli Lilly(2) Teva(3) Novartis
(1) The Journal of Headache and Pain, Junior Editor, 2020-present(2) Frontiers in Neurology, Review Editor, 2021-2022(3) Frontiers in Neurology, Associate Editor, 2022-present(3) Brain Sciences, Topic Editor, 2020-2022
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Rodrigo Bagur, MD,
None
NONE
None
Journal of the American Heart Association, Guest Associate Editor, 2021 to dateEuroIntervention, Section Editor, 2020 to date
NONE
NONE
NONE
Commercial, Medtronic Canada, less than 5000/year.
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Amado Jimenez-Ruiz, MD and
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Luciano A. Sposato, MD, MBA, FRCPC
Bayer Canada
NONE
(1) Boehringer Ingelheim (speaker honoraria), Pfizer, Kathleen & Dr Henry Barnett Chair in Stroke Research (Western University, London, Ontario, Canada)(2) Edward and Alma Saraydar Neurosciences Fund (London Health Sciences Foundation)(3) Pfizer INC.(4) Gore(5) Boehringer Ingelheim
(1) Editorial board: Neurology.(2) Editorial board: Stroke Journal. Section editor for Neurocardiology.(3) Editorial board and Associate Editor: JAHA(4) Chair: Brain and Heart Task Force, World Stroke Organization
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Biotechnological and Applied Clinical Sciences (S.S., R.O.), University of L'Aquila, Italy; Neurovascular Research Laboratory (A.M.H., C.A.), Department of Radiology, Vascular Division (A.M.H., C.A.), and Headache and Neuropathic Pain Division (A.M.H.), Department of Neurology, Massachusetts General Hospital, Boston; Division of Cardiology (R.B.), Western University, London, Ontario, Canada; Department of Neurology (A.J.-R.), Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; Departments of Clinical Neurological Sciences, Epidemiology and Biostatistics and Anatomy and Cell Biology (L.A.S.), Schulich School of Medicine and Dentistry, Heart & Brain Laboratory (L.A.S.), and Robarts Research Institute (L.A.S.), Western University; and Lawson Health Research Institute (L.A.S.), London, Ontario, Canada.
- Correspondence
Dr. Sposato lucianosposato{at}gmail.com
Article usage
Letters: Rapid online correspondence
- Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update
- Raffaele Ornello, Neurologist, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
- Luciano A. Sposato, Neurologist, Department of Clinical Neurological Sciences, Western University, London, ON, Canada
- Simona Sacco, Neurologist, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Submitted March 03, 2023 - Reader Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update
- Adrian Scutelnic, MD, Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- Simon Jung, MD, Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- Christoph J Schankin, MD, Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
Submitted January 16, 2023
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.